Literature DB >> 21111618

Receptor activity and conformational analysis of 5'-halogenated resiniferatoxin analogs as TRPV1 ligands.

Kwang Su Lim1, Dong Wook Kang, Yong Soo Kim, Myeong Seop Kim, Seul-Gi Park, Sun Choi, Larry V Pearce, Peter M Blumberg, Jeewoo Lee.   

Abstract

A series of 5'-halogenated resiniferatoxin analogs have been investigated in order to examine the effect of halogenation in the A-region on their binding and the functional pattern of agonism/antagonism for rat TRPV1 heterologously expressed in Chinese hamster ovary cells. Halogenation at the 5-position in the A-region of RTX and of 4-amino RTX shifted the agonism of parent compounds toward antagonism. The extent of antagonism was greater as the size of the halogen increased (I > Br > Cl > F) while the binding affinities were similar, as previously observed for our potent agonists. In this series, 5-bromo-4-amino RTX (39) showed very potent antagonism with K(i) (ant) = 2.81 nM, which was thus 4.5-fold more potent than 5'-iodo RTX, previously reported as a potent TRPV1 antagonist. Molecular modeling analyses with selected agonists and the corresponding halogenated antagonists revealed a striking conformational difference. The 3-methoxy of the A-region in the agonists remained free to interact with the receptor whereas in the case of the antagonists, the compounds assumed a bent conformation, permitting the 3-methoxy to instead form an internal hydrogen bond with the C4-hydroxyl of the diterpene.
Copyright © 2010 Elsevier Ltd. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 21111618      PMCID: PMC3420360          DOI: 10.1016/j.bmcl.2010.11.012

Source DB:  PubMed          Journal:  Bioorg Med Chem Lett        ISSN: 0960-894X            Impact factor:   2.823


  20 in total

1.  Functional properties of the high-affinity TRPV1 (VR1) vanilloid receptor antagonist (4-hydroxy-5-iodo-3-methoxyphenylacetate ester) iodo-resiniferatoxin.

Authors:  Guy R Seabrook; Kathy G Sutton; Wolfgang Jarolimek; Gregory J Hollingworth; Simon Teague; Janine Webb; Natalie Clark; Susan Boyce; Julie Kerby; Zahid Ali; Margaret Chou; Richard Middleton; Gregory Kaczorowski; A Brian Jones
Journal:  J Pharmacol Exp Ther       Date:  2002-12       Impact factor: 4.030

2.  Duration of desensitization and ultrastructural changes in dorsal root ganglia in rats treated with resiniferatoxin, an ultrapotent capsaicin analog.

Authors:  A Szallasi; F Joo; P M Blumberg
Journal:  Brain Res       Date:  1989-11-27       Impact factor: 3.252

Review 3.  Recent developments in transient receptor potential vanilloid receptor 1 agonist-based therapies.

Authors:  Keith R Bley
Journal:  Expert Opin Investig Drugs       Date:  2004-11       Impact factor: 6.206

4.  Similarities and differences in the structure-activity relationships of capsaicin and resiniferatoxin analogues.

Authors:  C S Walpole; S Bevan; G Bloomfield; R Breckenridge; I F James; T Ritchie; A Szallasi; J Winter; R Wrigglesworth
Journal:  J Med Chem       Date:  1996-07-19       Impact factor: 7.446

5.  Iodo-resiniferatoxin, a new potent vanilloid receptor antagonist.

Authors:  P Wahl; C Foged; S Tullin; C Thomsen
Journal:  Mol Pharmacol       Date:  2001-01       Impact factor: 4.436

6.  Synthesis and in vitro evaluation of a novel iodinated resiniferatoxin derivative that is an agonist at the human vanilloid VR1 receptor.

Authors:  Mark E McDonnell; Sui Po Zhang; Adrienne E Dubin; Scott L Dax
Journal:  Bioorg Med Chem Lett       Date:  2002-04-22       Impact factor: 2.823

7.  Structure-activity relations of polyfunctional diterpenes of the daphnane type. I. Revised structure for resiniferatoxin and structure-activity relations of resiniferonol and some of its esters.

Authors:  W Adolf; B Sorg; M Hergenhahn; E Hecker
Journal:  J Nat Prod       Date:  1982 May-Jun       Impact factor: 4.050

8.  Design of a high-affinity competitive antagonist of the vanilloid receptor selective for the calcium entry-linked receptor population.

Authors:  Attila Tóth; Peter M Blumberg; Zili Chen; Alan P Kozikowski
Journal:  Mol Pharmacol       Date:  2004-02       Impact factor: 4.436

9.  Resiniferatoxin, a phorbol-related diterpene, acts as an ultrapotent analog of capsaicin, the irritant constituent in red pepper.

Authors:  A Szallasi; P M Blumberg
Journal:  Neuroscience       Date:  1989       Impact factor: 3.590

10.  Resiniferatoxin-amide and analogues as ligands for protein kinase C and vanilloid receptors and determination of their biological activities as vanilloids.

Authors:  G Acs; J Lee; V E Marquez; S Wang; G W Milne; L Du; N E Lewin; P M Blumberg
Journal:  J Neurochem       Date:  1995-07       Impact factor: 5.372

View more
  3 in total

1.  New transient receptor potential vanilloid subfamily member 1 positron emission tomography radioligands: synthesis, radiolabeling, and preclinical evaluation.

Authors:  Daisy van Veghel; Jan Cleynhens; Larry V Pearce; Ian A DeAndrea-Lazarus; Peter M Blumberg; Koen Van Laere; Alfons Verbruggen; Guy Bormans
Journal:  ACS Chem Neurosci       Date:  2013-02-19       Impact factor: 4.418

2.  The carbonate analogues of 5'-halogenated resiniferatoxin as TRPV1 ligands.

Authors:  Kwang Su Lim; Hobin Lee; Sung Eun Kim; Tae-Hwan Ha; Jihyae Ann; Karam Son; Sun Choi; Wei Sun; Larry V Pearce; Ian A DeAndrea-Lazarus; Peter M Blumberg; Jeewoo Lee
Journal:  Eur J Med Chem       Date:  2013-08-09       Impact factor: 6.514

3.  Sulfur(vi) fluoride exchange as a key reaction for synthesizing biaryl sulfate core derivatives as potent hepatitis C virus NS5A inhibitors and their structure-activity relationship studies.

Authors:  Youngsu You; Hee Sun Kim; Jung Woo Park; Gyochang Keum; Sung Key Jang; B Moon Kim
Journal:  RSC Adv       Date:  2018-09-12       Impact factor: 4.036

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.